A New Paradigm for Cancer Treatment

More info

Personalized Gene Therapy

More info

Targeting Natural Immune Homeostasis Pathways

More info

Immunomodulatory Mechanisms

Repurposing Oncology Treatment - Working to test successful combination strategies and acceptable toxicity profile.

read more

Clinical Trials

The field of immuno-oncology is expanding, and we plan to create clinical trials that will investigate the immunotherapies that restore the immune response or overcome immune- suppressive signals.

read more

Employee Opportunities

To apply, please send resume to jobs@tbrexa.com

read more

tBrexa's Approach to Regulating Gene Therapy

We are developing immunotherapeutics to treat and/or prevent the reoccurrence of cancers.  

Cancer is caused by abnormal cells that grow in an uncontrolled manner. These cells proliferate and metastasize throughout the body causing tumors which can cause organ failure and death. The current treatments such as surgery, radiation, and chemotherapy have limited therapeutic effects and significant undesirable side effects. T-Cell immunotherapy market across the world is expected to reach $30B by 2030. 

Image 1

Partnering Opportunities

 We are committed to broadening our portfolio of new and innovative novel therapeutics and we are looking to secure alliances along the different stages of drug development and technology. 

read more
Image 2


More to come

read more

tBrexa BioSciences Inc.


241 Francis Ave

Mansfield, MA 02048

E-mail: info@tbrexa.com

© | Privacy Policy
Website designed by pricelessgrindinvestments